Pharmaceutical - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

126 to 150 of 7172 results

Orexo presents new Ph III data for Zubsolv

07-12-2014

The US subsidiary of Swedish drug developer Orexo says that, in the ISTART Phase III study, Zubsolv (buprenorphine…

NeurologicalOrexoPharmaceuticalResearchSuboxoneZubsolv

Bayer files for European approval of hemophilia A drug BAY 81-8973

06-12-2014

German pharma major Bayer has filed an application for marketing authorization to the European Medicines…

BAY 81-8973BayerEuropeHematologyPharmaceuticalRegulation

FDA advisory panel backs Actavis’ ceftazidime-avibactam

06-12-2014

Ireland-headquartered generic drugs major Actavis says that the Anti-Infective Drugs Advisory Committee…

ActavisAntibiotics and Infectious diseasesAstraZenecaceftazidime-avibactamPharmaceuticalRegulationUSA

EMA update on review of studies performed at GVK Biosciences site in Hyderabad, India

06-12-2014

Some European Union member states have decided to suspend the marketing authorizations of medicines that…

EuropeGVK BiosciencesIndiaPharmaceuticalRegulationResearch

Turning a constraint into an enabler: transparency round-table at Veeva's commercial summit 2014

Turning a constraint into an enabler: transparency round-table at Veeva's commercial summit 2014

05-12-2014

In one of the opening sessions, cloud-based life sciences provider Veeva’s co-founder and president…

BMI SystemEuropeInterviewsPharmaceuticalRegulationVeeva

Mixed findings from IQWiG on added benefit for Eliquis

05-12-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined a dossier on Eliquis…

Bristol-Myers SquibbCardio-vascularEliquisGermanyPfizerPharmaceuticalPricingRegulation

Patient access to novel non-insulin treatments is sub-optimal in China

05-12-2014

With respect to the treatment of type 2 diabetes in China, patient access to premium-priced agents is…

AstraZenecaByettaChinaDiabetesHealthcareJanuviaMarkets & MarketingMerck & CoPharmaceutical

Takeda receives Breakthrough designation for ixazomib

Takeda receives Breakthrough designation for ixazomib

05-12-2014

Japanese drug major Takeda Pharmaceutical’s has been granted Breakthrough Therapy designation from…

ixazomibPharmaceuticalRare diseasesRegulationTakeda PharmaUSA

Sanofi accused of $34 million kickbacks by former paralegal employee

Sanofi accused of $34 million kickbacks by former paralegal employee

05-12-2014

Allegations have been made that French drug major Sanofi and members of its executive took part in a…

FranceLantusLegalNephrology and HepatologyPharmaceuticalSanofi

Parkinson's disease pipeline at highly innovative stage, with 37% of products first-in-class

Parkinson's disease pipeline at highly innovative stage, with 37% of products first-in-class

05-12-2014

The current pipeline of treatments for Parkinson’s disease is a site of great innovation, with 37%…

GBI ResearchGeriatricsNeurologicalPharmaceuticalResearch

GlaxoSmithKline abandons plans to divest Established Products portfolio

05-12-2014

In what has come as something of a surprise, UK pharma major GlaxoSmithKline has abandoned its plan to…

EuropeGlaxoSmithKlineMergers & AcquisitionsNorth AmericaPharmaceutical

Recently-announced timeline of UK Patent Box changes helps address uncertainty, says patent attorney

04-12-2014

Following UK Chancellor of the Exchequer George Osborne’s confirmation of an overhaul of the Patent…

FinancialPatentsPharmaceuticalResearchUK

Meda and Cipla sue Apotex to enforce Dymista patents

Meda and Cipla sue Apotex to enforce Dymista patents

04-12-2014

Swedish pharma company Meda Pharmaceuticals and Indian drugmaker Cipla today have sued Canada-headquartered…

ApotexCiplaDymistaLegalMedaPharmaceuticalRespiratory and PulmonaryUSA

Australian CCC grants interim authorization for Medicines Australia’s ‘transparent’ Code of Conduct

Australian CCC grants interim authorization for Medicines Australia’s ‘transparent’ Code of Conduct

04-12-2014

The Australian Competition and Consumer Commission has granted interim authorization to trade body Medicines…

AustraliaAustralian Competition and Consumer CommissionPharmaceuticalPharmacologyPolitics

Added benefit of Lundbeck’s Selincro not proven, says IQWiG

04-12-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment…

GermanyLundbeckNeurologicalPharmaceuticalPricingRegulationSelincro

ABPI welcomes Chancellor’s decision to increase rate of R&D tax credits

04-12-2014

In his Autumn Statement yesterday, UK Chancellor of the Exchequer, George Osborne said he wants to help…

FinancialPharmaceuticalResearchUK

UK’s BTG buys PneumRx for up to $475 million

04-12-2014

Dutch venture capital firm Forbion Capital Partners has sold its portfolio company PneumRx to UK health…

BTGMergers & AcquisitionsPharmaceuticalPneumRxRespiratory and Pulmonary

EMA committee concludes no evidence Fluad caused deaths

EMA committee concludes no evidence Fluad caused deaths

04-12-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that…

EuropeFluadNovartisPharmaceuticalRegulationVaccines

ADMA’s lead product meets primary endpoint in Phase III trial

04-12-2014

US-based biopharmaceutical company ADMA Biologics says that its lead product candidate RI-002 has demonstrated…

ADMA BiologicsImmunologicalsPharmaceuticalResearchRI-002USA

Age-related macular degeneration treatment market to reach $10 billion by 2023

Age-related macular degeneration treatment market to reach $10 billion by 2023

04-12-2014

The market for treatments of age-related macular degeneration across seven major countries will almost…

AvastinEuropeEyleaFovistaLucentisMarkets & MarketingOphthalmicsPharmaceuticalUSA

Biogen shares rise as it pledges to progress Alzheimer’s drug

Biogen shares rise as it pledges to progress Alzheimer’s drug

03-12-2014

US biotech firm Biogen Idec has said that it will pursue a Phase III program for its Alzheimer’s disease…

BIIB037Biogen IdecNeurologicalPharmaceuticalResearchUSA

Actelion submits selexipag for EMA marketing authorization in PAH

Actelion submits selexipag for EMA marketing authorization in PAH

03-12-2014

Swiss biotech firm Actelion has submitted a centralized Marketing Authorization Application to the European…

ActelionCardio-vascularEuropePharmaceuticalRegulationselexipag

PTC launches Translarna for DMD in Germany

PTC launches Translarna for DMD in Germany

03-12-2014

US biotech company PTC Therapeutics has announced that Translarna (ataluren) is commercially available…

CNS DiseasesGermanyMarkets & MarketingPharmaceuticalPTC TherapeuticsTranslarna

126 to 150 of 7172 results

Back to top